Clinical Trials Directory

Trials / Unknown

UnknownNCT02426645

Microcirculatory Alteration and Biomarkers: New Approach for Early Assessment of Septic Multi-organ Dysfunction

Status
Unknown
Phase
Study type
Observational
Enrollment
25 (estimated)
Sponsor
Prof. Dr. Marc-H. Dahlke, Ph. D. · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to investigate associations between early structural cellular injury and microvascular alteration with progression of septic organ dysfunction according to total SOFA-Score (an ICU-scoring system - the Sequential Organ Failure Assessment Score). Patients will be monitored for renal (TIMP-2, IGFBP7), and intestinal biomarkers (plasma i-FABP) in conjunction with kidney and muscle vascular bed microvascular perfusion analysis assessed by contrast-enhanced ultrasonography (CEUS). In parallel, a comprehensive analysis of patients' immunological status will be conducted using an established, on-site immune monitoring panel. The ultimate goal of this study is an early identification of septic patients developing multiorgan dysfunction which may facilitate a timely novel intervention in the future to improve outcome.

Conditions

Timeline

Start date
2015-04-01
Primary completion
2019-01-01
Completion
2019-04-01
First posted
2015-04-27
Last updated
2018-05-07

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT02426645. Inclusion in this directory is not an endorsement.